Alprostadil and Spironolactone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Alprostadil (alprostadil) and Spironolactone (spironolactone). Common drug interactions include nephrogenic anaemia among females and lymphocyte count decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Alprostadil and Spironolactone. It is created by eHealthMe based on reports of 85 people who take the same drugs from the FDA, and is updated regularly.

What is Alprostadil?

Alprostadil has active ingredients of alprostadil. It is often used in erection problems. eHealthMe is studying from 2,653 Alprostadil users. Check the latest studies of Alprostadil.

What is Spironolactone?

Spironolactone has active ingredients of spironolactone. It is often used in acne. eHealthMe is studying from 122,947 Spironolactone users. Check the latest studies of Spironolactone.



On Jul, 05, 2026

85 people who take Alprostadil and Spironolactone together, and have interactions are studied.

Alprostadil and Spironolactone drug interactions.

What are the common drug interactions of Alprostadil and Spironolactone, by gender? *:

female:

  1. Nephrogenic anaemia (anaemia due to kidney disease)
  2. Anaemia (lack of blood)
  3. Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
  4. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  5. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  6. Angina pectoris (chest pain due to ischemia of the heart muscle)
  7. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  8. Blood glucose increased
  9. Extremity necrosis (death of body tissue of arms and legs)
  10. Gastroenteritis (inflammation of stomach and intestine)

male:

  1. Lymphocyte count decreased
  2. Neutrophil count increased (excess than normal number of neutrophil a type of blood cell)
  3. Pain in extremity
  4. Upper respiratory tract infection
  5. Urinary tract infection
  6. White blood cell count increased
  7. Cardiac failure
  8. Anaemia (lack of blood)
  9. Bk virus infection
  10. Blood glucose increased

What are the common drug interactions of Alprostadil and Spironolactone, by age (0-1 to 60+)? *:

0-1:

  1. Apnoeic attack
  2. Neonatal disorder (disease of neonates)
  3. Blood pressure systolic decreased
  4. Heart rate increased
  5. Infantile apnoeic attack (episodes where breathing stops temporarily in infant)
  6. Neonatal hyponatraemia (low body temperature in neonate)
  7. Apnoea (suspension of external breathing)
  8. Blood potassium increased
  9. Body temperature decreased
  10. Cardiac failure

2-9:

  1. Haematuria (presence of blood in urine)

10-19:

n/a

20-29:

  1. Bone pain
  2. Death

30-39:

  1. Back pain
  2. Blood creatinine increased
  3. Blood urea increased
  4. Blood urine present
  5. C-reactive protein increased
  6. Haemoglobin decreased
  7. Incision site pain
  8. Lymphocyte count decreased
  9. Musculoskeletal discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves)
  10. Neutrophil count increased (excess than normal number of neutrophil a type of blood cell)

40-49:

  1. Pain in extremity
  2. Anaemia (lack of blood)
  3. Blood glucose increased
  4. Blood urea increased
  5. C-reactive protein increased
  6. Diarrhoea
  7. Incision site haemorrhage (bleeding from incision site)
  8. Incision site pain
  9. Lymphocyte count decreased
  10. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)

50-59:

  1. Nasopharyngitis (inflammation of the nasopharynx)
  2. Osteoporosis (bones weak and more likely to break)
  3. Overdose
  4. Protein urine present
  5. Upper respiratory tract infection
  6. Wound complication
  7. Palpitations (feelings or sensations that your heart is pounding or racing)
  8. Pyrexia (fever)
  9. Abdominal distension
  10. Bloody discharge

60+:

  1. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  2. Nephrogenic anaemia (anaemia due to kidney disease)
  3. Extremity necrosis (death of body tissue of arms and legs)
  4. Iron deficiency anaemia
  5. Peripheral arterial occlusive disease (reproducible ischemic muscle pain)
  6. Peripheral circulatory failure
  7. Anaemia (lack of blood)
  8. Pain in extremity
  9. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  10. Acute myocardial infarction (acute heart attack)

What are the existing conditions these people have? *

  1. High Blood Pressure: 29 people, 34.12%
  2. Urination - Excessive Volume: 20 people, 23.53%
  3. Sedation: 13 people, 15.29%
  4. Productive Cough: 11 people, 12.94%
  5. Constipation: 11 people, 12.94%
  6. Infection: 8 people, 9.41%
  7. Pain: 8 people, 9.41%
  8. Heart Disease: 7 people, 8.24%
  9. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 7 people, 8.24%
  10. Electrolyte Imbalance: 7 people, 8.24%

* Approximation only. Some reports may have incomplete information.

Do you take Alprostadil and Spironolactone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Alprostadil and Spironolactone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Alprostadil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Spironolactone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Alprostadil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Spironolactone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on alprostadil and spironolactone (the active ingredients of Alprostadil and Spironolactone, respectively), and Alprostadil and Spironolactone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: